Susquehanna International Group, LLP Kronos Bio, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 50,249 shares of KRON stock, worth $43,214. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,249
Previous 104,285
51.82%
Holding current value
$43,214
Previous $129,000
61.24%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding KRON
# of Institutions
56Shares Held
19.8MCall Options Held
9.3KPut Options Held
100-
Vida Ventures Advisors, LLC2.77MShares$2.38 Million3.24% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$1.76 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.65 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.61MShares$1.39 Million0.03% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.24 Million0.1% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $48.8M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...